Screening Test Standards Clause Samples

Screening Test Standards. The lab shall use initial and confirmatory testing approved by the Substance Abuse and Mental Health Services Administration (SAMHSA) and/or certified laboratory standards which meet the requirements of the Food and Drug Administration for commercial distribution. The following drugs or classes of drugs may be tested: Marijuana metabolites 50ng/ml Cocaine metabolites. 150ng/ml Codeine 2000ng/ml Morphine 2000ng/ml Hydrocodone 300ng/ml Hydromorphone 300ng/ml Oxycodone 100ng/ml Oxymorphone 100ng/ml 6-Acetylmorphone (Heroin). 10ng/ml Phencyclidine 25ng/ml Amphetamines. 500ng/ml ▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇/▇▇ ▇▇▇▇▇▇▇▇▇ 300ng/ml MDMA*. 500ng/ml MDA** 500ng/ml Benzodiazepines. 300ng/ml Barbiturates. 300ng/ml Fentanyl 0.75ng/ml Meperidine 100 ng/ml Nalbuphine 5 ng/ml Pentazocine 75 ng/ml Buprenorphine (Suboxone). 10ng/ml (These numbers may be revised by the City to remain consistent with HHS guidelines.) *Methylenedioxymethamphetamine **Methylenedioxyamphetamine

Screening Test Standards. The lab shall use an immunoassay which meets the requirements of the food and drug administration for commercial distribution. The following initial immunoassay test cutoff levels shall be used when screening urine specimens to determine whether they are negative for the eight (8) drugs or classes of drugs: Initial Test Level Marijuana metabolites 50ng/mL Cocaine metabolites 300 150ng/mL Opiate metabolites* 2000ng/mL Phencyclidine 25ng/mL Amphetamines 1000 500ng/mL Methaqualone 200ng/mL Benzodiazepines 300ng/mL Barbiturates 200ng/mL Oxycontin 100ng/mL Ecstasy 500ng/mL *If immunoassay is specific for free morphine, the initial testing level is 25ng/mL (these numbers may be revised by the city to remain consistent with HHS guidelines.) Confirmatory test standards. All urine specimens identified as positive on the initial screening test shall be confirmed using GC/MS techniques at the cutoff levels listed below. All confirmations shall be by quantitative analysis. Confirmatory Test Levels Marijuana metabolites* 15ng/mL Cocaine metabolites** 150 100ng/mL Opiates: morphine 2000ng/mL Codeine 300 2000ng/mL Phencyclidine 25ng/mL Amphetamines: amphetamine 500 250ng/mL Methamphetamine 500 250ng/mL Methaqualone 200ng/mL Benzodiazepines 300ng/mL Barbiturates 200ng/mL Oxycontin 50 100ng/mL Ecstasy 300 250ng/mL * Delta 9 Tetrahydrocannabinol 9 Carboxylic Acid **Benzoyl ecgonine (These numbers may be revised by the city to remain consistent with HHS guidelines.) Testing for other prescription drugs. Any tests for prescription drugs not listed above shall use the screening test cut-off levels and the confirmatory GC/MS test cut-off levels for such drugs established by the testing laboratory selected by the city in accordance with the standards established by this contract or HHS standards, if any.

Screening Test Standards. The lab shall use an immunoassay which meets the requirements of the Food and Drug Administration for commercial distribution. The following initial immunoassay test cutoff levels shall be used when screening urine specimens to determine whether they are negative for the eight (8) drugs or classes of drugs: Initial Test Level Marijuana metabolites 50ng/ml Cocaine metabolites. 300ng/ml Opiate metabolites*. 2000ng/ml Phencyclidine. 25ng/ml Amphetamines. 1000ng/ml Methaqualone. 200ng/ml Benzodiazepines. ng/mi Barbiturates. 200ng/ml OxyContin. 100ng/ml Ecstasy. 500ng/ml *If immunoassay is specific for free morphine, the initial testing level is 25ng/ml (These numbers may be revised by the City to remain consistent with HHS guidelines.)

Screening Test Standards. The lab shall use initial and confirmatory testing approved by the Substance Abuse and Mental Health Services Administration (SAMHSA) and/or certified laboratory standards which meet the requirements of the Food and Drug Administration for commercial distribution. The following drugs or classes of drugs may be tested: Marijuana metabolites. 50ng/ml Cocaine metabolites. 150ng/ml Codeine 2000ng/ml Morphine 2000ng/ml Hydrocodone 300ng/ml Hydromorphone 300ng/ml Oxycodone 100ng/ml Oxymorphone 100ng/ml 6-Acetylmorphone (Heroin). 10ng/ml Phencyclidine 25ng/ml Amphetamines. 500ng/ml Methamphetamine 500ng/ml Methadone 300ng/ml MDMA*. 500ng/ml MDA** 500ng/ml Benzodiazepines. 300ng/ml Barbiturates. 300ng/ml (These numbers may be revised by the City to remain consistent with HHS guidelines.) *Methylenedioxymethamphetamine **Methylenedioxyamphetamine

Screening Test Standards. The following initial immunoassay test cutoff levels shall be used when screening specimens to determine whether they are negative for the five (5) drugs or classes of drugs: Cocaine metabolites ...................................... 300 ng/ml Opiate metabolites ........................................ 300 ng/ml Phencyclidine ................................................ 25 ng/ml Amphetamines . ............................................. 1000 ng/▇▇ ▇. Confirmatory Test Standards. All specimens identified as positive on the initial drug screening test shall be confirmed using GC/MS techniques at the cutoff levels listed below. All confirmations shall be by quantitative analysis. Concentrations which exceed the linear region of the standard curve shall be documented. Confirmatory Test Level Marijuana metabolites*.................................. 15 ng/ml Cocaine metabolites** ................................... 150 ng/ml Opiates: Amphetamines * Delta-9-tetrahydrocannabinol-9-carboxylic acid ** Benzoylecgonine

Screening Test Standards. THE LAB SHALL USE AN IMMUNOASSAY WHICH MEETS THE REQUIREMENTS OF THE FOOD AND DRUG ADMINISTRATION FOR COMMERCIAL DISTRIBUTION. THE FOLLOWING INITIAL IMMUNOASSAY TEST CUTOFF LEVELS SHALL BE USED WHEN SCREENING URINE SPECIMENS TO DETERMINE WHETHER THEY ARE NEGATIVE FOR THE EIGHT (8) DRUGS OR CLASSES OF DRUGS: MARIJUANA METABOLITES 50NG/ML COCAINE METABOLITES 300NG/ML OPIATE METABOLITES* 2000NG/ML PHENCYCLIDINE 25NG/ML ▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇/▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇ 200NG/ML BENZODIAZEPINES NG/MI BARBITURATES 200NG/ML OXYCONTIN 100NG/ML ECSTASY 500NG/ML *IF IMMUNOASSAY IS SPECIFIC FOR FREE MORPHINE, THE INITIAL TESTING LEVEL IS 25NG/ML (THESE NUMBERS MAY BE REVISED BY THE CITY TO REMAIN CONSISTENT WITH HHS GUIDELINES.) CONFIRMATORY TEST STANDARDS. ALL URINE SPECIMENS IDENTIFIED AS POSITIVE ON THE INITIAL SCREENING TEST SHALL BE CONFIRMED USING GC/MS TECHNIQUES AT THE CUTOFF LEVELS LISTED BELOW. ALL CONFIRMATIONS SHALL BE BY QUANTITATIVE ANALYSIS. MARIJUANA METABOLITES* 15NG/ML COCAINE METABOLITES** 150NG/ML OPIATES: MORPHINE 2000NG/ML CODEINE 300NG/ML PHENCYCLIDINE 25NG/ML AMPHETAMINES: AMPHETAMINE 500NG/ML METHAMPHETAMINE 500NG/ML METHAQUALONE 200NG/ML BENZODIAZEPINES 300NG/ML BARBITURATES 200NG/ML OXYCONTIN 50NG/ML ECSTASY 300NG/ML (THESE NUMBERS MAY BE REVISED BY THE CITY TO REMAIN CONSISTENT WITH HHS GUIDELINES.) TESTING FOR OTHER PRESCRIPTION DRUGS. ANY TESTS FOR PRESCRIPTION DRUGS NOT LISTED ABOVE SHALL USE THE SCREENING TEST CUT-OFF LEVELS AND THE CONFIRMATORY GC/MS TEST CUT-OFF LEVELS FOR SUCH DRUGS ESTABLISHED BY THE TESTING LABORATORY SELECTED BY THE CITY IN ACCORDANCE WITH THE STANDARDS ESTABLISHED BY THIS CONTRACT OR HHS STANDARDS, IF ANY.

Screening Test Standards. The lab shall use an immunoassay which meets the requirements of the Food and Drug Administration for commercial distribution. The following initial immunoassay test cutoff levels shall be used when screening urine specimens to determine whether they are negative for the twelve (12) drugs or classes of drugs: Marijuana metabolites. . . . . . . . . . . 50ng/ml Cocaine metabolites. 300ng/ml Opiate metabolites*. 2000ng/ml Phencyclidine 25ng/ml Amphetamines. 1000ng/ml Methaqualone 200ng/ml Benzodiazepines. 300ng/ml Barbiturates. 200ng/ml OxyContin 100ng/ml Ecstasy 500ng/ml Synthetic Marijuana (K2/Spice) 20-5.0ng/ml Synthetic Cathinones (Bath Salts) 20ng/ml *If immunoassay is specific for free morphine, the initial testing level is 25ng/ml (These numbers may be revised by the City to remain consistent with HHS guidelines.)